Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy

Authors

Daniel Gorelik, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Amy Frantz, Division of Oncology, Children's National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Jeffrey S. Dome, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Brian K. Reilly, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Document Type

Journal Article

Publication Date

2-1-2024

Journal

Ear, nose, & throat journal

Volume

103

Issue

2

DOI

10.1177/01455613211040578

Abstract

Recurrent respiratory papillomatosis is a condition caused by human papilloma virus, usually sub types 6 and 11. Papillomas are benign neoplasms that are most commonly found on the larynx and can be often associated with significant airway involvement. Frequency of episodes varies among patients as do the clinical symptoms. Patients often present with symptoms such as hoarseness but there is potential for respiratory compromise and even complete airway obstruction.

APA Citation

Gorelik, Daniel; Frantz, Amy; Dome, Jeffrey S.; and Reilly, Brian K., "Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy" (2024). GW Authored Works. Paper 4451.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/4451

Department

Surgery